Dangers ‍of Tramadol: Understanding the Risks ⁤and Controversies

Tramadol, also ⁢known as green-yellow medicine,⁣ is⁢ a⁢ painkiller that has been linked to several⁢ deaths due to its‌ high side effects. The Food and Drug ⁣Administration (FDA) has ​issued a‌ warning about the dangers of Tramadol, which can cause nausea, vomiting, dizziness, and drowsiness if ‌taken in excessive⁢ doses.

The FDA has emphasized that Tramadol is a dangerous drug that should only be used in cases of severe pain and under the supervision of‍ a doctor. Taking ⁣too much medicine can lead to cardiovascular failure, seizures, ⁣and respiratory​ system slowdown, which can be​ fatal.

The Pharmacy Council’s‍ Stance on Tramadol

The Pharmacy Council has acknowledged the issue of Tramadol ⁢and is currently coordinating with relevant agencies to address the problem. However, the‍ council’s decision to elevate Tramadol to a specially controlled drug ‌has sparked controversy among some individuals.

Some ⁣people have expressed concerns⁢ that making Tramadol a specially ​controlled drug will make it difficult ‌for ‌patients‍ who genuinely need the medication to access it. Others have⁣ argued‌ that the move will not solve ‌the problem of addiction and ⁤may even drive the sale of Tramadol underground.

Public Reaction to the ⁤Pharmacy Council’s Decision

Comments on ​the Pharmacy Council’s post have been divided, with some people supporting the decision to control Tramadol and others opposing it. Some ‌have argued that Tramadol is a necessary medication for patients with​ chronic diseases and cancer, while others have expressed concerns ⁤about the potential for addiction.

One Facebook user commented, ​”Tramadol‍ or green-yellow pills are painkillers from the same ⁤group as morphine, which has​ many medical benefits. However,‍ it​ is used in the wrong way ⁤by ‌teenagers who mix ⁢it with other drugs. Therefore, there is ‌a⁣ push for Tramadol to become a specially controlled drug.”

Another user commented, “The elevation of Tramadol to a ‌specially controlled drug has⁢ resulted ⁣in⁣ cancer patients, kidney disease patients,⁢ and patients allergic to NSAIDs who actually need to use the drug⁢ being unable ‌to buy it at pharmacies. They ⁢have to go to hospitals to get the medication, which is​ like taking a patient hostage.”

Conclusion

The controversy surrounding Tramadol⁣ highlights the need for⁢ a balanced approach ⁢to addressing the⁣ problem ‍of addiction. While ​controlling Tramadol may help reduce ⁣its misuse, it⁢ is essential to ensure that patients who genuinely‌ need the medication can access​ it. The ​Pharmacy ‌Council and ‍relevant agencies must work together to ⁤find a solution that addresses ⁣the‍ concerns of all stakeholders.